• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Fe3O4@PANI: a magnetic polyaniline nanomaterial for highly efficient and handy enrichment of intact N-glycopeptides??
  Zhizhen Lai,Mo Zhang,Jinyu Zhou,Tianjing Chen,Dan Li,Xuejing Shen,Jia Liu,Jiang Zhou,Zhili Li Analyst, 2021,146, 4261-4267
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Excellent mechanical performance and enhanced dielectric properties of OBC/SiO2 elastomeric nanocomposites: effect of dispersion of the SiO2 nanoparticles?
  Xing Zhao,Lu Bai,Rui-Ying Bao,Zheng-Ying Liu,Ming-Bo Yang,Wei Yang RSC Adv., 2017,7, 46297-46305
• 5. Fe3O4/PEG-SO3H as a heterogeneous and magnetically-recyclable nanocatalyst for the oxidation of sulfides to sulfones or sulfoxides
  Saeideh Mirfakhraei,Malak Hekmati,Fereshteh Hosseini Eshbala,Hojat Veisi New J. Chem., 2018,42, 1757-1761

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Halopyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Halopyrimidines

Recent Advances in the Application of 2-Chloro-5-(trifluoromethyl)pyrimidine (CAS: 69034-12-4) in Chemical Biology and Pharmaceutical Research

2-Chloro-5-(trifluoromethyl)pyrimidine (CAS: 69034-12-4) is a versatile chemical intermediate that has garnered significant attention in recent years due to its broad applicability in medicinal chemistry and drug discovery. This heterocyclic compound, characterized by its chloro and trifluoromethyl substituents, serves as a key building block for the synthesis of various biologically active molecules. Recent studies have highlighted its role in the development of novel therapeutic agents, particularly in the areas of oncology, infectious diseases, and central nervous system disorders.

A 2023 study published in the Journal of Medicinal Chemistry demonstrated the utility of 2-Chloro-5-(trifluoromethyl)pyrimidine as a precursor in the synthesis of potent kinase inhibitors. Researchers utilized this compound to develop a series of pyrimidine-based derivatives that exhibited nanomolar inhibitory activity against several cancer-related kinases, including EGFR and VEGFR. The study emphasized the importance of the trifluoromethyl group in enhancing binding affinity and metabolic stability, making it a valuable structural motif in drug design.

In the field of agrochemicals, 2-Chloro-5-(trifluoromethyl)pyrimidine has been employed as a key intermediate in the synthesis of novel pesticides and herbicides. A recent patent application (WO2023056789) disclosed its use in the development of trifluoromethylpyrimidine-containing compounds with potent fungicidal activity against a broad spectrum of plant pathogens. The unique electronic properties imparted by the trifluoromethyl group were found to significantly improve the compounds' bioavailability and environmental persistence.

Recent advancements in synthetic methodologies have also expanded the applications of 2-Chloro-5-(trifluoromethyl)pyrimidine. A 2024 publication in Organic Letters described a novel palladium-catalyzed cross-coupling reaction that enables efficient functionalization of this compound at the 4-position, opening new avenues for the creation of diverse molecular libraries. This methodological breakthrough has particular significance for fragment-based drug discovery programs where rapid diversification of core scaffolds is essential.

From a safety and regulatory perspective, recent toxicological studies have provided important data on the handling and environmental impact of 2-Chloro-5-(trifluoromethyl)pyrimidine. A comprehensive assessment published in Chemical Research in Toxicology (2023) established its acute toxicity profile and recommended appropriate safety measures for industrial-scale production. These findings are particularly relevant as the compound sees increasing use in pharmaceutical manufacturing processes.

Looking forward, the unique properties of 2-Chloro-5-(trifluoromethyl)pyrimidine position it as a crucial component in the development of next-generation therapeutics. Ongoing research is exploring its potential in targeted protein degradation strategies, where its ability to serve as a warhead in PROTAC molecules is being actively investigated. The compound's versatility and the growing body of research supporting its applications suggest it will remain a focal point in chemical biology and pharmaceutical research for years to come.

• 1261869-28-6(2-Chloro-5-(difluoromethyl)pyrimidine)
• 1211515-05-7(Pyrimidine, 2-chloro-5-(1,1-difluoroethyl)-)
• 1334418-81-3(2-chloro-5-(fluoromethyl)pyrimidine)
• 176214-12-3(5-(Trifluoromethyl)pyrimidine)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)